Skip to content

The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period

Pulmonary rehabilitation to improve pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029459
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-03
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

new coronavirus pneumonia (COVID-19)

Interventions

experimental group:Pulmonary rehabilitation+Conventional treatment
control group:Conventional treatment

Sponsors

1.Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients diagnosed as Pneumonia caused by new coronavirus infection (2019-nCoV); 2. virus turned negative after treatment; 3. aged 18-70 years old; 4. patients with clear consciousness; 5. Signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with serious illnesses, such as heart, liver, kidney, endocrine diseases and hematopoietic system disease; 2. Pregnant or lactating women; 3. Patients with mental confusion, with a history of drug abuse or dependence, who allergic to study medication, who have participated in another clinical trial within 3 months,or who have other conditions not suitable for clinical study.

Design outcomes

Primary

MeasureTime frame
pulmonary function;St Georges respiratory questionnaire, SGRQ;

Secondary

MeasureTime frame
Modified Barthel Index, MBI;Incidence of adverse events;6-minute walk test, 6MWT;

Countries

China

Contacts

Public ContactWenguang Xia

1.Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine

docxwg@163.com+86 13377897278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026